STOCK TITAN

Solventum (NYSE: SOLV) director gains 1,980 shares in RSU exercise

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Solventum Corp director Susan D. DeVore exercised fully vested Restricted Stock Units to receive Common Stock as equity compensation. She converted 1,980 RSUs, each representing a contingent right to one share of Common Stock, into 1,980 shares at an exercise price of $0.00 per share.

After the transaction, she directly holds 5,544 shares of Solventum Common Stock. The filing shows a routine derivative exercise/conversion with no open‑market buying or selling activity.

Positive

  • None.

Negative

  • None.
Insider DeVore Susan D.
Role Director
Type Security Shares Price Value
Exercise Restricted Stock Units 1,980 $0.00 --
Exercise Common Stock 1,980 $0.00 --
Holdings After Transaction: Restricted Stock Units — 0 shares (Direct); Common Stock — 5,544 shares (Direct)
Footnotes (1)
  1. Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement. The RSUs are fully vested.
RSUs exercised 1,980 units Restricted Stock Units converted to Common Stock on March 27, 2026
Exercise price $0.00 per share Price per share for RSU conversion into Common Stock
Shares received 1,980 shares Common Stock received from RSU exercise
Shares held after transaction 5,544 shares Direct Solventum Common Stock holdings following the exercise
Derivative exercises 1 transaction, 1,980 shares Exercise-or-conversion events summarized in Form 4 transactionSummary
RSU expiration date May 13, 2034 Original expiration date noted for the RSU derivative award
Restricted Stock Units financial
"Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
derivative exercise/conversion financial
"transaction_action": "derivative exercise/conversion""
contingent right financial
"represents a contingent right to receive 1 share of the issuer's Common Stock"
fully vested financial
"The RSUs are fully vested."
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
DeVore Susan D.

(Last)(First)(Middle)
1750 YANKEE DOODLE ROAD

(Street)
EAGAN MINNESOTA 55121

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Solventum Corp [ SOLV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/27/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock03/27/2026M1,980A$05,544D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)03/27/2026M1,980 (2)05/13/2034Common Stock1,980$00D
Explanation of Responses:
1. Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.
2. The RSUs are fully vested.
Remarks:
/s/Megan Bombick, attorney-in-fact for Susan D. DeVore03/30/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)
Solventum Corporation

NYSE:SOLV

View SOLV Stock Overview

SOLV Rankings

SOLV Latest News

SOLV Latest SEC Filings

SOLV Stock Data

11.00B
147.50M
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
ST. PAUL